PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects por D'Alessio A, Rimassa L, Cortellini A, Pinato DJ

Ligazón do recurso

The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges por D'Alessio A, Prete MG, Cammarota A, Personeni N, Rimassa L

Ligazón do recurso

Closed-incision negative pressure therapy as a strategy to reduce sternal wound infection in identified high-risk patients: a multicentre propensity matched study por Suelo-Calanao, RL, D’Alessio, A, Hutton, S, Krasopoulos, G, Muppiri, V, Cartwright, C, Parvez, A, Nikolaidis, N, Loubani, M

NAADP links histamine H1 receptors to secretion of von Willebrand factor in human endothelial cells. por Esposito, B, Gambara, G, Lewis, A, Palombi, F, D'Alessio, A, Taylor, L, Genazzani, A, Ziparo, E, Galione, A, Churchill, G, Filippini, A

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma por Manfredi GF, Celsa C, John C, Jones C, Acuti N, Scheiner B, Fulgenzi CAM, Korolewicz J, Pinter M, Gennari A, Mauri FA, Pirisi M, Minisini R, Vincenzi F, Burlone M, Rigamonti C, Donadon M, Cabibbo G, D'Alessio A, Pinato DJ

Ligazón do recurso